CryoLife, Inc. preserves and distributes human tissues for transplantation in the United States and internationally. The company also develops, manufactures, and commercializes medical devices for cardiac and vascular applications. The company also distributes surgical sealants and hemostats, including BioGlue Surgical Adhesive, BioFoam Surgical Matrix and PerClot and revascularization technologies for treating patients with stable angina that is not responsive to conventional therapy. Further, the company provides a laser console system for the treatment of coronary artery disease; and single use, fiber-optic handpieces to treat patients with severe angina. It distributes its products through field service representatives, cardiac specialists, direct field representatives, and independent distributors.

Acquired Companies: AuraZyme Pharmaceuticals, Inc., Hemosphere, Inc.